Cellular phenotypes in human stenotic lesions from haemodialysis vascular access

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2786-2791

  Roy Chaudhury, Prabir ^a   Wang, Yang ^a   Krishnamoorthy, Mahesh ^b   Zhang, Jianhua ^a   Banerjee, Rupak ^b   Munda, Rino ^b   Heffelfinger, Sue ^a   Arend, Lois ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cellular phenotypes; Dialysis access; Venous neointimal hyperplasia

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL MARKER; DESMIN; VIMENTIN;

ARTERIOVENOUS FISTULA; ARTICLE; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; GRAFT FAILURE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROPHAGE; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTILITY; VASCULAR ACCESS; VEIN ANASTOMOSIS; VEIN OCCLUSION;

ACTINS; ARTERIES; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL MOVEMENT; CONSTRICTION, PATHOLOGIC; DESMIN; FIBROBLASTS; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; MYOBLASTS, SMOOTH MUSCLE; PHENOTYPE; POLYTETRAFLUOROETHYLENE; RENAL DIALYSIS; TUNICA INTIMA; VEINS; VIMENTIN;

EID: 69249083963     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn708     Document Type: Article

References (28)

1. Eggers P. Trends in vascular access procedures and expenditures in Medicares ESRD program. In: Henry M (ed.). Vascular Access for Hemodialysis VII. Chicago, 2001, pp 133-143. Precept Press Inc. (August 2001)
2. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-535
3. Lee H, Manns B, Taub K et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40: 611- 622
4. McCarley P, Wingard RL, Shyr Y et al. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001; 60: 1164-1172
5. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol1995; 147: 668-677
6. Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334
7. Stracke S, Konner K, Kostlin I et al. Increased expression of TGFbeta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 2002; 61: 1011-1019
8. WeissMF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001; 37: 970-980
9. Roy-Chaudhury P, Arend L, Zhang J et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 2007; 50: 782- 790
10. Shi Y, O'Brien JE, Fard A et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation1996; 94: 1655-1664
11. Shi Y, O'Brien JE Jr, Mannion JD et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation1997; 95: 2684-2693
12. Shi Y, Pieniek M, Fard A et al. Adventitial remodeling after coronary arterial injury. Circulation 1996; 93: 340-348
13. Kalra M, Miller VM. Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J Vasc Res 2000; 37: 576-584
14. Li G, Chen SJ, Oparil S et al. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000; 101: 1362-1365
15. Maeng M, Olesen PG, Emmertsen NC et al. Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron Artery Dis 2001; 12: 285-293
16. Zalewski A, Shi Y. Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol 1997; 17: 417- 422
17. Tomas JJ, Stark VE, Kim JL et al. Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts. J Vasc Res 2003; 40: 266-275
18. Mallawaarachchi CM, Weissberg PL, Siow RC. Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs? FASEB J 2006; 20: 1686-1688
19. Oparil S, Chen SJ, Chen YF et al. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res 1999; 44: 608-614
20. Sata MYH, Nagai R. Circulating recipient cells contribute to graft coronary arteriolosclerosis. J Cardiol 2002; 39: 48-49
21. Clowes AW, Clowes MM, Fingerle J et al. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 1989; 14(Suppl 6): S12-S15
22. Clowes A, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacological control of intimal hyperplasia. J Vasc Surg1991; 13: 885-891
23. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517
24. O'Brien JE Jr, Shi Y, Fard A et al. Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 1997; 114: 38-45
25. Misra S, DohertyMG,Woodrum D et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 2005; 68: 2890-2900
26. Meng QH, Jamal W, Hart SL et al. Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia. Hum Gene Ther 2006; 17: 717-727
27. Kelly B,Melhem M, Zhang J et al. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant2006; 21: 2425-2431
28. CapliceNM,Wang S,TraczMet al.Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol 2007; 293: F470-F475